Piper Sandler raised the firm’s price target on Intuitive Surgical (ISRG) to $620 from $610 and keeps an Overweight rating on the shares. The firm notes the company reported full Q4 results that topped consensus on both the top and bottom line. Management reaffirmed its initial 2026 procedure guidance provided earlier this month.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $750 from $740 at Bernstein
- Intuitive Surgical price target lowered to $590 from $635 at Citi
- Intuitive Surgical: Durable Growth, Expanding Moat, and Attractive Upside Support Buy Rating and $616 Target
- Intuitive Surgical: Durable Growth, Operating Leverage, and Premium-Valuation Upside Through 2026
- Closing Bell Movers: Intel falls 12% on soft guidance